Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

DolCas is Raising the Chocolate Bar with Concentrated Fish Collagen


News provided by

DolCas Biotech

Jul 01, 2025, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Non-GMO Morikol® delivers the clinically validated lowest-dose pure marine tripeptides that go undetected in chocolate

LANDING, N.J., July 1, 2025 /PRNewswire/ -- Nutraceutical innovator DolCas Biotech, LLC, has successfully infused beneficial marine collagen tripeptides into a chocolate bar. Each square (about 8g) contains 1g of Morikol®, an ultra-low-molecular weight of fish collagen tripeptide with clinically validated effectiveness at this uniquely minimal dose.

Continue Reading
DolCas is Raising the Chocolate Bar with Concentrated Fish Collagen
DolCas is Raising the Chocolate Bar with Concentrated Fish Collagen

Merging wellness with indulgence, Morikol breaks into the flourishing functional foods arena by demonstrating its stellar capabilities to seamlessly integrate concentrated collagen into milk, dark, or white chocolate without affecting the comforting flavor, aroma, or texture of these popular confections.

Morikol is a next-generation, Type I & III fish collagen tripeptide that offers high bioavailability and rapid absorption due to its exceptionally low molecular weight and unique structure. Morikol boasts an abundant content of functional three-amino-acid sequenced tripeptides composed of glycine, proline, and hydroxyproline. These structures, known as "GPH," have been shown to stimulate collagen generation, as well as the synthesis of the hyaluronic acid and ceramides enzymes essential for maintaining the skin barrier and cell membrane structure.

Less is More 

"Most collagen ingredients come in 5g-10g doses," explains K. G. Rao, founder and CEO of DolCas Biotech. "Morikol's low concentration of the bioactive component makes it ideal for innovative delivery formats. One square of chocolate can now deliver a full clinical dose of collagen peptides, whether for beauty-from-within or joint comfort, and still satisfy the most discerning chocolate lover's palate. Our 'less is more' collagen concept is transforming how people experience wellness by bringing a touch of sensory joy to the routine of supplementing with collagen."

DolCas' Morikol fish collagen is a fine concentrated powder that is odorless, neutral in flavor, and highly soluble. This advancement breaks away from the conventional and often inconvenient need for bulky collagen powders, offering consumers a delicious and indulgent alternative to capsules or pills in alignment with modern preferences.

"This is the only fish collagen clinically studied to deliver measurable benefits for skin health at a daily 1g dose, or for joint mobility at a 2g daily dose," affirms Rao.

In one clinical trial conducted on 53 women volunteers, a daily intake of 1g Morikol over a period of 12 weeks resulted in substantial improvements in skin elasticity and dermal hydration, and elicited visible skin benefits as along with protection from sun-induced aging. Overall, the group taking Morikol showed a 10.5-fold greater improvement in wrinkle visual scores compared to the placebo group at 12 weeks. These benefits were already beginning to show after six weeks of intake, particularly around the cheeks and crow's feet.

In another 10-week clinical study conducted on 64 participants complaining of mild knee pain, a 2g daily dose of Morikol reduced fluid build-up around the joints, as well as mitigated cracking and pain.

Previous lab and animal assessments have demonstrated the direct uptake of Morikol's tripeptides across the intestinal barrier and into the bloodstream intact through PEPT1 transporters owed to its unique hydrolyzed enzyme formulation. These tripeptides have been shown to increase mRNA expression of collagen production in a cell study.

"Morikol's piscine tripeptides are designed to reach vulnerable and damaged sites of the skin, bone, and tendons where it activates osteoblasts and fibroblasts, in turn helping promote collagen synthesis, boosting bone and connective tissue integrity as well as keeping joints lubricated," Rao elaborates.

"Morikol is non-GMO, sustainable, allergen-friendly, and is completely free of any fishy aroma or flavor, making it a perfect candidate for expansion into functional foods," adds Rao. "Our full spectrum, clean-label collagen offers a turn-key opportunity to elevate chocolate products into the wellness arena, without compromising on their classic treats' flavor and the enjoyment of snacking," concludes Rao.

Morikol is both kosher and halal certified and meets stringent quality standards, tested to ensure no dioxins, PCB's, hormones, or other synthetics, rendering it a high-purity, trusted collagen ingredient.

About DolCas Biotech

DolCas Biotech, LLC is a leader in branded, science-based nutraceutical ingredients. Headquartered in New Jersey, the company specializes in developing full-spectrum, clinically validated bioactive ingredients that meet modern wellness needs without compromising on natural integrity. With a portfolio that includes market-shaping innovations such as the company's flagship ingredient, Curcugen® and now Morikol®, DolCas remains at the forefront of clean-label, functional ingredient science.

For more information:

Company Contact:

Press Contact:

DolCas Biotech, LLC

NUTRiPR

K. G. Rao

Founder and CEO of DolCas Biotech

Liat Simha

Tel: +972-9-974-2893

Email: [email protected]

Email: [email protected] 

Web: www.dolcas-biotech.com

Website: www.nutripr.com 

Photo: https://mma.prnewswire.com/media/2722743/DOLCAS_Chocolate.jpg

SOURCE DolCas Biotech

21%

more press release views with 
Request a Demo

Modal title

Also from this source

DolCas Biotech Marine Collagen Boosts the Morning Coffee Break

DolCas Biotech Marine Collagen Boosts the Morning Coffee Break

Leading nutraceutical developer DolCas Biotech, LLC is expanding Morikol®, its marine collagen into the functional beverage space, particularly...

More Releases From This Source

Explore

Supplementary Medicine

Supplementary Medicine

Health Care & Hospitals

Health Care & Hospitals

Food & Beverages

Food & Beverages

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.